Trials / Available
AvailableNCT05561985
Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Incyte Corporation · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Expanded access use of Itacitinib to treat a single patient with aplastic anemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Itacitinib |
Timeline
- First posted
- 2022-09-30
- Last updated
- 2025-06-08
Source: ClinicalTrials.gov record NCT05561985. Inclusion in this directory is not an endorsement.